Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
Reparixin 1200 Mg Three Times a Day as Add-on Therapy to Standard of Care to Limit Disease Progression in Hospitalised Adult Patients With Covid-19 Other Community-acquired Pneumonia. A Multinational,
Sponsored by IQVIA RDS Inc.
Active
$302.9K Funding
4 People
External
Related Topics
covid-19,
pneumonia,
therapy,
disease progression,
hospitalized patients
People
Cathleen Wilson
(CD)
Medicine
﹒Clinical Research Coordinator II
Christian Bime
Principal Investigator (PI)
Medicine
﹒Associate Professor
Jarrod Mosier
Co-Investigator (COI)
Dept of Emergency Medicine
﹒Professor
Beth Campbell
(CD)
Dept of Emergency Medicine
﹒Clinical Research Manager I
